Skip to main content

Genius Sports Ltd

corporate_fare Company Profile

Genius Sports Ltd

GENI·NYSE·Trade & Services·CIK 0001834489

Genius Sports Limited provides technology-driven products and services to the sports, sports betting, and sports media industries across the Americas, Europe, and internationally. The company offers technology infrastructure for collecting, integrating, and distributing live optical tracking, event data, and video for league operations. It also provides streaming solutions, including technology, automatic production, and distribution, enabling sports organizations to commercialize video footage of their games. Genius Sports delivers end-to-end integrity services to sports leagues, featuring full-time active monitoring technology that uses mathematical algorithms to identify and flag suspicious betting activity in global betting markets, alongside online and offline educational and consultancy services. The company develops tools to enhance fan engagement for sports leagues, offers digital content and gamification solutions, and provides consumer insights and fan intelligence services. Additionally, Genius Sports supplies live sports data collection, pre-game and in-game odds feeds, and risk management services such as customer profiling, monitoring incoming bets, automated acceptance and rejection of bets, and limit setting. It also provides live streaming services. Key products include BetVision, an interactive single-screen live streaming solution with integrated bet slips, real-time statistics, and personalized viewing modes, and FanHub, an advertising solution for creating, delivering, and optimizing digital marketing campaigns, including data-driven personalized ad creative and programmatic media buying. Genius Sports Limited was founded in 2001 and is headquartered in London, the United Kingdom. The company changed its name from Genius Sports Group Limited in April 2021.

Genius Sports Ltd (NYSE:GENI) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 10 items for GENI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-18, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for GENI spans 4, 6-K, 20-F.

Recent high-impact activity:

  • CEO Mark Locke Sells $5.3M of Genius Sports Stock, Enters Zero-Cost Collar on 4.4M Shares
  • Genius Sports Tops Q2 Targets and Lifts Full-Year Forecast on Legend Synergies
  • Genius Sports to Provide Official Data & Integrity for Liga MX US Sponsorship
  • Genius Sports Raises Full-Year Guidance Significantly Post-Legend Acquisition
  • Genius Sports Completes $844M Legend Acquisition, Secures $1.045B Debt Financing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$669.49M
Net Income
-$111.58M
Diluted EPS
-$0.44
Op. Cash Flow
$86.39M
Free Cash Flow
$64.54M
Gross Profit
$153.84M
Operating Income
-$151.33M
Cash & Equivalents
$280.56M
Debt / Equity
0.00×
Net Margin
-16.7%
Shares Outstanding
10M sh
Source: 20-F · filed 2026-03-17 · accession 0001193125-26-110749

Short Interest & Short Volume

7.97 days to cover

FINRA reported short interest of 38,134,278 shares in GENI as of the September 15, 2026 settlement, a 6.1% increase from the prior period — about 8.0 days to cover at its recent average daily volume. On October 2, 2026, 56.1% of GENI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)38,134,278 shares as of September 15, 2026
Change vs prior period▲ 6.1%
Days to cover7.97 at avg daily volume of 4,785,522
Daily short volume (FINRA facilities)56.1% of 2,958,973 shares on October 2, 2026
5-day average short volume53.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

GENI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with G →
$6.03 +0.01% today
52-week range · as of 2026-09-18 $3.83 – $13.69
Market cap
$1.67B
Volume
7.9M (1.2× avg)
3-mo avg 6.7M
Live data · 2026-10-05 03:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GENI - Latest Insights

GENI
Sep 17, 2026, 8:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $6.49
Real-time Price: $6.03 info
Change: -$0.460 (-7%) info
Market Cap: $1.671B info
GENI
Aug 06, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $8.31
Real-time Price: $6.03 info
Change: -$2.28 (-27%) info
Market Cap: $1.671B info
GENI
Jun 10, 2026, 5:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $6.03 info
Change: -$0.990 (-14%) info
Market Cap: $1.671B info
GENI
May 07, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.55
Real-time Price: $6.03 info
Change: +$1.48 (+33%) info
Market Cap: $1.671B info
GENI
May 01, 2026, 6:10 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $6.03 info
Change: +$1.63 (+37%) info
Market Cap: $1.671B info
GENI
May 01, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.41
Real-time Price: $6.03 info
Change: +$1.62 (+37%) info
Market Cap: $1.671B info
GENI
Mar 17, 2026, 4:05 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $4.99
Real-time Price: $6.03 info
Change: +$1.04 (+21%) info
Market Cap: $1.671B info
GENI
Mar 04, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $6.03 info
Change: -$0.570 (-9%) info
Market Cap: $1.671B info
GENI
Feb 13, 2026, 7:04 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $6.15
Real-time Price: $6.03 info
Change: -$0.120 (-2%) info
Market Cap: $1.671B info
GENI
Feb 05, 2026, 6:08 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $8.60
Real-time Price: $6.03 info
Change: -$2.57 (-30%) info
Market Cap: $1.671B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets